Metraipolis › archive › dc_1dc55751d17e

Highlight selection of radiochemistry and radiopharmacy developments by editorial board — Europe PMC PMID:41042435

Source
Europe PMC (en)
Original
https://europepmc.org/article/MED/41042435
DOI
10.1186/s41181-[numero omesso]-y
License (as archived)
solo-consultazione
Archived
2026-11-09T14:27:52.111Z
SHA-256 of the archived text
28623e2f2b655abd42561958565d75d2efcb37b5331653761292539612d62455
Stable URL of this page
https://metraipolis.com/documento/dc_1dc55751d17e

How to cite

Highlight selection of radiochemistry and radiopharmacy developments by editorial board — Europe PMC PMID:41042435 — Europe PMC (en), https://europepmc.org/article/MED/41042435 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_1dc55751d17e (Metraipolis archive dc_1dc55751d17e, sha256 28623e2f2b655abd42561958565d75d2efcb37b5331653761292539612d62455)
BibTeX
@misc{dc1dc55751d17e,
  title = {Highlight selection of radiochemistry and radiopharmacy developments by editorial board — Europe PMC PMID:41042435},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/41042435},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_1dc55751d17e; sha256 28623e2f2b655abd42561958565d75d2efcb37b5331653761292539612d62455},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/41042435. Agents can read the archived copy with the MCP tool read_document.